Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Sponsor: Galderma R&D
Summary
This is a randomized, no-treatment-controlled, evaluator-blinded, multi-center study to evaluate the effectiveness and safety of Restylane® Contour in correction of temple hollowing.
Official title: A Randomized, No-treatment-controlled, Evaluator-blinded, Multi-center Study to Evaluate the Effectiveness and Safety of Restylane Contour in the Treatment of Temple Hollowing
Key Details
Gender
All
Age Range
22 Years - Any
Study Type
INTERVENTIONAL
Enrollment
225
Start Date
2023-03-14
Completion Date
2024-12-11
Last Updated
2026-05-22
Healthy Volunteers
No
Conditions
Interventions
Restylane Contour
a sterile, biodegradable, transparent gel of nonanimal cross-linked HA (20 mg/mL) with the addition of lidocaine hydrochloride (3 mg/mL)
Locations (15)
Galderma Research Site
Phoenix, Arizona, United States
Galderma Research Site
Encino, California, United States
Galderma Research Site
Los Angeles, California, United States
Galderma Research Site
Redondo Beach, California, United States
Galderma Research Site
Solana Beach, California, United States
Galderma Research Site
Vista, California, United States
Galderma Research Site
Washington D.C., District of Columbia, United States
Galderma Research Site
Adventura, Florida, United States
Galderma Research Site
Boynton Beach, Florida, United States
Galderma Research Site
Coral Gables, Florida, United States
Galderma Research Site
New Orleans, Louisiana, United States
Galderma Research Site
New York, New York, United States
Galderma Research Site
Chapel Hill, North Carolina, United States
Galderma Research Site
Wilmington, North Carolina, United States
Galderma Research Site
Nashville, Tennessee, United States